Target intelligence / Profile preview

Rho family-interacting cell polarization regulator 1 (RIPOR1)

Target
RIPOR1
Molecular classification
Other (adapter/scaffold protein; not a receptor, enzyme, ion channel, or transcription factor), RHO GTPase regulator
01

Overview

Rho family-interacting cell polarization regulator 1 (RIPOR1) is an adapter and scaffold protein that directly binds active RHO GTPases (notably RHOA, RHOB, and RHOC) through a conserved N-terminal RHO-binding motif, thereby negatively regulating their activity. This action is crucial for directing cell polarity and migration, including Golgi apparatus reorientation in response to external stimuli and wounding. RIPOR1’s functions are mediated through protein-protein interactions, especially in linking RHO GTPases to Golgi-localizing proteins. Its expression is widespread across tissues, and dysregulation has been implicated contextually in cancer and immune cell migration, with emerging evidence supporting broader disease relevance. While it is not classified as a classical receptor or enzyme, it plays a vital role in cellular signaling networks involving the actin cytoskeleton and directional movement. No clinically approved drugs directly target RIPOR1, and its utility as a biomarker is presently investigational.

Other names
RIPOR1FAM65AKIAA1930FLJ13725Family with sequence similarity 65 member AProtein FAM65ARho family-interacting cell polarization regulator 1
02

Mechanism of action

Scaffold/adapter function modulating RHO GTPase activity through direct binding. Influences Golgi reorientation and cell migration by bridging RHO GTPases to Golgi-localizing partners

03

Biological functions

Negative regulation of RHO GTPase activity (especially RHOA, RHOB, RHOC)Regulation of cell polarityRegulation of directional cell migration (including Golgi apparatus reorientation during wound response)Signal transduction (by affecting cytoskeletal organization)Scaffold/adaptor activity (bridging RHO proteins to Golgi-localizing proteins)
04

Disease associations

Cancer (upregulation has been reported in several gastrointestinal tumors and may play context-dependent oncogenic/tumor suppressor roles)Inflammation (regulates immune cell migration and response)Other roles possible; experimental evidence is still emerging
05

Safety considerations

No direct safety concerns or therapeutic challenges specific to targeting RIPOR1 have been reportedThe essential role in cell migration/polarity suggests that systemic inhibition could potentially affect normal tissue homeostasis; risk is theoretical and not characterized clinically
06

Interacting drugs

No drugs directly targeting RIPOR1 are reported in current clinical or preclinical studies

1 more in the full profile.

07

Biomarkers

No established clinical biomarkers for patient selection or monitoring efficacy involving RIPOR1RIPOR1 expression may be a candidate biomarker in certain cancer contexts, but this is currently experimental

Beyond the preview

Go deeper on Rho family-interacting cell polarization regulator 1 (RIPOR1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rho family-interacting cell polarization regulator 1 (RIPOR1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call